Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current country site or be switched to your country?
Two-parameter flow cytometric analysis of IL-22 expression in human peripheral blood mononuclear cells (PBMCs). PBMCs were cultured in complete tissue culture medium with Phorbol 12-Myristate 13-Acetate (PMA; Sigma, 50 ng/ml) and Ionomycin (Sigma, 500 ng/ml) in the presence of BD GolgiPlug™ Protein Transport Inhibitor (Cat. No. 555029) for 6 hours. The cells were harvested, then fixed and permeabilized using BD Cytofix™ Fixation Buffer (Cat. No. 554655) and BD Perm/Wash™ buffer (Cat. No. 554723). The cells were then stained with PE Mouse Anti-Human CD4 (Cat. No. 555347/561843/561844) and either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 565365; Left Panel) or Alexa Fluor® 647 Mouse Anti-IL-Human 22 antibody (Cat. No. 567160/567161; Right Panel) at 0.125 µg/test. Bivariate pseudocolor density plots showing the correlated expression of IL-22 (or Ig Isotype control staining) versus CD4 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Two-parameter flow cytometric analysis of IL-22 expression in human peripheral blood mononuclear cells (PBMCs). PBMCs were cultured in complete tissue culture medium with Phorbol 12-Myristate 13-Acetate (PMA; Sigma, 50 ng/ml) and Ionomycin (Sigma, 500 ng/ml) in the presence of BD GolgiPlug™ Protein Transport Inhibitor (Cat. No. 555029) for 6 hours. The cells were harvested, then fixed and permeabilized using BD Cytofix™ Fixation Buffer (Cat. No. 554655) and BD Perm/Wash™ buffer (Cat. No. 554723). The cells were then stained with PE Mouse Anti-Human CD4 (Cat. No. 555347/561843/561844) and either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 565365; Left Panel) or Alexa Fluor® 647 Mouse Anti-IL-Human 22 antibody (Cat. No. 567160/567161; Right Panel) at 0.125 µg/test. Bivariate pseudocolor density plots showing the correlated expression of IL-22 (or Ig Isotype control staining) versus CD4 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Two-parameter flow cytometric analysis of IL-22 expression in human peripheral blood mononuclear cells (PBMCs). PBMCs were cultured in complete tissue culture medium with Phorbol 12-Myristate 13-Acetate (PMA; Sigma, 50 ng/ml) and Ionomycin (Sigma, 500 ng/ml) in the presence of BD GolgiPlug™ Protein Transport Inhibitor (Cat. No. 555029) for 6 hours. The cells were harvested, then fixed and permeabilized using BD Cytofix™ Fixation Buffer (Cat. No. 554655) and BD Perm/Wash™ buffer (Cat. No. 554723). The cells were then stained with PE Mouse Anti-Human CD4 (Cat. No. 555347/561843/561844) and either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 565365; Left Panel) or Alexa Fluor® 647 Mouse Anti-IL-Human 22 antibody (Cat. No. 567160/567161; Right Panel) at 0.125 µg/test. Bivariate pseudocolor density plots showing the correlated expression of IL-22 (or Ig Isotype control staining) versus CD4 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Two-parameter flow cytometric analysis of IL-22 expression in human peripheral blood mononuclear cells (PBMCs). PBMCs were cultured in complete tissue culture medium with Phorbol 12-Myristate 13-Acetate (PMA; Sigma, 50 ng/ml) and Ionomycin (Sigma, 500 ng/ml) in the presence of BD GolgiPlug™ Protein Transport Inhibitor (Cat. No. 555029) for 6 hours. The cells were harvested, then fixed and permeabilized using BD Cytofix™ Fixation Buffer (Cat. No. 554655) and BD Perm/Wash™ buffer (Cat. No. 554723). The cells were then stained with PE Mouse Anti-Human CD4 (Cat. No. 555347/561843/561844) and either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 565365; Left Panel) or Alexa Fluor® 647 Mouse Anti-IL-Human 22 antibody (Cat. No. 567160/567161; Right Panel) at 0.125 µg/test. Bivariate pseudocolor density plots showing the correlated expression of IL-22 (or Ig Isotype control staining) versus CD4 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Two-parameter flow cytometric analysis of IL-22 expression in human peripheral blood mononuclear cells (PBMCs). PBMCs were cultured in complete tissue culture medium with Phorbol 12-Myristate 13-Acetate (PMA; Sigma, 50 ng/ml) and Ionomycin (Sigma, 500 ng/ml) in the presence of BD GolgiPlug™ Protein Transport Inhibitor (Cat. No. 555029) for 6 hours. The cells were harvested, then fixed and permeabilized using BD Cytofix™ Fixation Buffer (Cat. No. 554655) and BD Perm/Wash™ buffer (Cat. No. 554723). The cells were then stained with PE Mouse Anti-Human CD4 (Cat. No. 555347/561843/561844) and either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 565365; Left Panel) or Alexa Fluor® 647 Mouse Anti-IL-Human 22 antibody (Cat. No. 567160/567161; Right Panel) at 0.125 µg/test. Bivariate pseudocolor density plots showing the correlated expression of IL-22 (or Ig Isotype control staining) versus CD4 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Two-parameter flow cytometric analysis of IL-22 expression in human peripheral blood mononuclear cells (PBMCs). PBMCs were cultured in complete tissue culture medium with Phorbol 12-Myristate 13-Acetate (PMA; Sigma, 50 ng/ml) and Ionomycin (Sigma, 500 ng/ml) in the presence of BD GolgiPlug™ Protein Transport Inhibitor (Cat. No. 555029) for 6 hours. The cells were harvested, then fixed and permeabilized using BD Cytofix™ Fixation Buffer (Cat. No. 554655) and BD Perm/Wash™ buffer (Cat. No. 554723). The cells were then stained with PE Mouse Anti-Human CD4 (Cat. No. 555347/561843/561844) and either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 565365; Left Panel) or Alexa Fluor® 647 Mouse Anti-IL-Human 22 antibody (Cat. No. 567160/567161; Right Panel) at 0.125 µg/test. Bivariate pseudocolor density plots showing the correlated expression of IL-22 (or Ig Isotype control staining) versus CD4 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Two-parameter flow cytometric analysis of IL-22 expression in human peripheral blood mononuclear cells (PBMCs). PBMCs were cultured in complete tissue culture medium with Phorbol 12-Myristate 13-Acetate (PMA; Sigma, 50 ng/ml) and Ionomycin (Sigma, 500 ng/ml) in the presence of BD GolgiPlug™ Protein Transport Inhibitor (Cat. No. 555029) for 6 hours. The cells were harvested, then fixed and permeabilized using BD Cytofix™ Fixation Buffer (Cat. No. 554655) and BD Perm/Wash™ buffer (Cat. No. 554723). The cells were then stained with PE Mouse Anti-Human CD4 (Cat. No. 555347/561843/561844) and either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 565365; Left Panel) or Alexa Fluor® 647 Mouse Anti-IL-Human 22 antibody (Cat. No. 567160/567161; Right Panel) at 0.125 µg/test. Bivariate pseudocolor density plots showing the correlated expression of IL-22 (or Ig Isotype control staining) versus CD4 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Two-parameter flow cytometric analysis of IL-22 expression in human peripheral blood mononuclear cells (PBMCs). PBMCs were cultured in complete tissue culture medium with Phorbol 12-Myristate 13-Acetate (PMA; Sigma, 50 ng/ml) and Ionomycin (Sigma, 500 ng/ml) in the presence of BD GolgiPlug™ Protein Transport Inhibitor (Cat. No. 555029) for 6 hours. The cells were harvested, then fixed and permeabilized using BD Cytofix™ Fixation Buffer (Cat. No. 554655) and BD Perm/Wash™ buffer (Cat. No. 554723). The cells were then stained with PE Mouse Anti-Human CD4 (Cat. No. 555347/561843/561844) and either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 565365; Left Panel) or Alexa Fluor® 647 Mouse Anti-IL-Human 22 antibody (Cat. No. 567160/567161; Right Panel) at 0.125 µg/test. Bivariate pseudocolor density plots showing the correlated expression of IL-22 (or Ig Isotype control staining) versus CD4 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Two-parameter flow cytometric analysis of IL-22 expression in human peripheral blood mononuclear cells (PBMCs). PBMCs were cultured in complete tissue culture medium with Phorbol 12-Myristate 13-Acetate (PMA; Sigma, 50 ng/ml) and Ionomycin (Sigma, 500 ng/ml) in the presence of BD GolgiPlug™ Protein Transport Inhibitor (Cat. No. 555029) for 6 hours. The cells were harvested, then fixed and permeabilized using BD Cytofix™ Fixation Buffer (Cat. No. 554655) and BD Perm/Wash™ buffer (Cat. No. 554723). The cells were then stained with PE Mouse Anti-Human CD4 (Cat. No. 555347/561843/561844) and either Alexa Fluor® 647 Mouse IgG2a, κ Isotype Control (Cat. No. 565365; Left Panel) or Alexa Fluor® 647 Mouse Anti-IL-Human 22 antibody (Cat. No. 567160/567161; Right Panel) at 0.125 µg/test. Bivariate pseudocolor density plots showing the correlated expression of IL-22 (or Ig Isotype control staining) versus CD4 were derived from gated events with the forward and side light-scatter characteristics of intact lymphocytes. Flow cytometry and data analysis were performed using a BD X-20 LSRFortessa™ Cell Analyzer System and FlowJo™ software. Data shown on this Technical Data Sheet are not lot specific.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
BD™ CompBeads can be used as surrogates to assess fluorescence spillover (Compensation). When fluorochrome conjugated antibodies are bound to CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cell and CompBead to ensure that BD Comp beads are appropriate for your specific cellular application.
The MH22B2 monoclonal antibody specifically recognizes human Interleukin-22 (IL-22), which is encoded by the IL22 gene. Cross-reactivity of MH22B2 mAb to mouse IL-22 (which shares 79% amino acid identity with human IL-22) has been observed by ELISA and by flow cytometry of HEK293 cells transfected with mouse IL-22 and TH17-differentiated CD4-positive T cells from C57BL/6 mice. IL-22 (with or without other cytokines) is secreted by many T-cell and innate-lymphoid-cell populations. Evidence that IL-22 plays a key role in mucosal immunity includes the restricted expression of the alpha subunit of the heterodimeric IL-22 receptor, called IL-22R1, on epithelial cells and cells of epithelial origin. At epithelial surfaces, IL-22 elicits antimicrobial defenses and maintains epithelial integrity. Alternatively, uncontrolled IL-22 production can result in certain inflammatory disorders. Regulation of IL-22 expression is complex, involving other cytokines (eg, IL-6, IL-23, and TGF-β) and many transcription factors, (eg, AHR, c-Maf, STAT3, RORɤT, BATF, and others).
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.